je.st
news
Tag: flat
Tod's FY profit slumps on flat revenues
2015-03-13 16:52:00| Daily apparel & textile news and comment - from just-style.com
Footwear-led fashion group Tod's recorded a substantial reduction in full-year profits in 2014, with revenues essentially flat on the year before.
Tags: flat
profit
revenues
tods
Articulating Wall Mount holds 27-42 in. flat panel displays.
2015-03-12 13:31:07| Industrial Newsroom - All News for Today
With closed depth of 1.6 in. and fully opened extension of 16.4 in. Model FP-MLPAB supports most 27–42 in. flat panel displays up to 55 lb. Unit offers fully adjustable 10° tilt, 3° list adjustment, and ±45° of rotation. Designed to install into single stud, mount has maximum flat panel hole pattern of 400 x 400 mm. Other features include black powder coat finish, integrated cable management system and level, and mounting rails that accept padlocks for security.
Stock futures point to flat open after recent decline
2015-03-09 14:52:58| Industrial Machines - Topix.net
U.S. stock index futures pointed to a flat open on Monday, after two straight weeks of declines on major indexes and as the benchmark S&P 500 comes off its biggest one-day loss in about two months. Wall Street's recent downtrend has come as investors speculated over whether interest rates could be raised sooner than expected.
Fizz in Thai Beverage, F&N share price but flat for Dukang
2015-03-03 13:56:42| Beverages - Topix.net
The three Singapore-listed beverage companies have shown mixed performance since New Year, with shares of Thai Beverage and Fraser & Neave enjoying price gain while those of Dukang Distillers stayed flat. Nonetheless, the three companies still combined to an average price gain of 3.26 per cent in the year so far, while maintaining a dividend yield of 2.7 per cent on average, the latest My Gateway report released by Singapore Exchange on March 3 showed.
Vivus - Flat Qsymia Scripts Point To Needed Shift
2015-03-02 21:52:57| Biotech - Topix.net
It is no secret that the Vivus's anti-obesity pill Qsymia have been pretty flat for over a year. If a flat sales trajectory is not troubling enough, the fact that Contrave from Orexigen is about to overtake Qsymia in just about 20 or 21 weeks should be a clear signal that a change is needed.
Sites : [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] next »